According to FutureWise analysis the market for neurovascular stent retrievers in 2023 is US$ 0.71 billion, and is expected to reach US$ 1.18 billion by 2031 at a CAGR of 6.5%.
The neurovascular stent retrievers are used for thrombectomy and blood flow restoration during acute embolic stroke. Neurovascular stent retrievers are particularly recognized for their ability to quickly restore the blood flow and effectively remove blood clots and thrombi from large intracranial arteries. Therefore, neurovascular stent retrievers are used in the treatment of endovascular strokes. Worldwide, ischemic strokes cause significant disability and death. Systemic thrombolysis with tissue plasminogen activator was an effective treatment for stroke, but other treatments were limited in treating severe stroke with thromboembolic occlusion. Recently, stent retrievers have been introduced for mechanical thrombectomy in patients with acute embolisms.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Neurovascular Stent Retrievers Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Neurovascular Stent Retrievers Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.